William Soliman

William Soliman has a diverse work experience in the pharmaceutical and medical industry. William is the founder and CEO of Accreditation Council for Medical Affairs (ACMA) and AG Sciences since 2015. William also founded US Pharmacy Lab-Pharmacy on Demand in 2014.

Prior to their entrepreneurial ventures, Soliman held leadership positions in various companies. William was the Head of Global Medical Affairs Strategy at Veeva Systems from 2015 to 2016. Before that, they worked at Eisai as the Medical Affairs Cardiovascular & Metabolic Diseases from 2013 to 2015. At Gilead Sciences, they served as the Director Field Medical, Cardiovascular Diseases and Director, Medical Science Liaison from 2009 to 2013.

Soliman also has experience in academia as a Clinical Professor of Medicine at Seton Hall University in 2010. William was the Senior Associate Director, MSLs Medical Affairs, Respiratory at Boehringer Ingelheim in 2009.

Earlier in their career, Soliman held the position of Vice President, Scientific & Medical Affairs at CME LLC from 2008 to 2009. William started their career at AbbVie as the Director, Medical Science Liaisons, Lipids, Lipidology from 2004 to 2008.

Overall, Soliman has extensive experience in medical affairs, scientific leadership, and entrepreneurship within the pharmaceutical industry.

William Soliman has a PhD from Columbia University, a Master's Degree from Columbia University, and a Bachelor's degree in Biochemistry from New York University. William also has a Master's Degree from Saint Peter's University. In addition, they have obtained certification as a Board Certified Medical Affairs Specialist from the Accreditation Council for Medical Affairs in 2016. William also has a background in investment banking from the Investment Banking Institute Business School Pty Ltd.